Endometrial cancer future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Mahshid)
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Endometrial cancer}}
{{Endometrial cancer}}
{{CMG}}; '''Associate Editor(s)-in-Chief:''' [[User: Shankar Kumar |Shankar Kumar, M.B.B.S.]] [mailto:kumarshankar@wikidoc.org]]


Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.


Please help WikiDoc by adding more content here. It's easy! Click [[Help:How_to_Edit_a_Page|here]] to learn about editing.
==Overview==
==Future or Investigational Therapies==
To minimize the complication of internal bleeding post lymph node dissection, [[sentinal node]] biopsy is being investigated for its usefulness in surgical staging. Even if it is found useful, clinicians have to understand the appropriate site for injecting the [[tracer]] and accurate mapping.


Though considerable data is lacking, it has been found that [[cytoreduction]] may be useful in women with intra-abdominal spread of cancer.


==References==
==References==
Line 17: Line 12:
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Gynecology]]
[[Category:Gynecology]]
[[Category:Oncology]]
[[Category: Needs content]]
[[Category:Needs content]]
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Gynecology]]
[[Category:Surgery]]

Latest revision as of 22:15, 26 November 2017